ALAN C. FOSTER,DANIEL W. GIL,JOHN E. DONELLO,URSULA V. STAUBLI
申请号：
BR112014001501
公开号：
BR112014001501A2
申请日:
2012.07.17
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention relates to a method for treating visual disorders mediated by lateral geniculate nucleus, superior colliculus and the visual cortex by administering to a patient in need of such treatment, compounds acting at the alpha 2 adrenergic receptors. "alpha-2 adrenergic modulators for treatment of visual disturbances mediated by central visual projections of the eye". The present invention relates to a method for treating visual disorders mediated by the lateral geniculate nucleus, superior colliculus, and cerebral cortex by administering to a patient in need of such treatment alpha-adrenergic receptor-acting compounds.abstract the present invention relates to a method for treating visual disorders mediated by lateral geniculate nucleus, superior colliculus and the visual cortex by administering to a patient in need of such treatment, compounds acting at the alpha 2 adrenergic receptors. tradução: resumo patente de invenção: "moduladores alfa-2 adrenérgicos para tratamento de distúrbios visuais mediados por projeções visuais centrais do olho". a presente invenção refere-se a um método para tratamento de distúrbios visuais mediados pelos núcleo geniculado lateral, colículo superior e córtex cerebral através de administração a um paciente com necessidade de tal tratamento de compostos que agem nos receptores alfa 2 adrenérgi-cos.
